Synapse - Works

Results (115370)

First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors

Meeting Abstract

Cooper, A. J.; Drilon, A. E.; Rotow, J. K.; Liu, S. V.; Gautschi, O.; Smith, K. E. R.; Lee, D. H.; Nagasaka, M.; Loong, H. H. F.; Pennell, N. A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer

Meeting Abstract

Lin, J. J.; Tan, D. S. W.; Kummar, S.; Patel, J. D.; Cermignani, L.; Dai, M. S.; Lassen, U. N.; Leyvraz, S.; Liu, Y.; Moreno, V.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Analytical and clinical validation of oncomine Dx target (ODxT) test and local testing for identifying patients with HER2 (ERBB2)-mutant (HER2m) non–small-cell lung cancer (NSCLC) for treatment with trastuzumab deruxtecan (T-DXd) in DESTINY-Lung01/02 (DL-01/02)

Meeting Abstract

Li, B. T.; De Langen, A.; Goto, K.; Vitazka, P.; Qi, Z.; Ha, T.; Velasco Roth, A. M.; Karnoub, M.; Feng, W.; Pereira, K.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting

Meeting Abstract

Yang, M.; MacEwan, J. P.; Sriteja Boppudi, S.; McClain, M.; O'Hara, R.; Liu, F.; Paik, P. K.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)

Meeting Abstract

Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Initial chemotherapy for locally advanced and metastatic NUT carcinoma: A report from the NUT carcinoma registry

Meeting Abstract

Luo, J.; Lee, E.; Sanchez, M.; Finstein, B.; Hertzler, H.; Luong, N.; Tamen, R.; Nguyen, T.; Paik, P. K.; Chaft, J. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Phase 1 trial of gavocabtagene autoleucel (gavo-cel, TC-210) in patients (pts) with treatment refractory mesothelioma and other mesothelin-expressing solid tumors

Meeting Abstract

Hassan, R.; Butler, M. O.; Oh, D. Y.; O'Cearbhaill, R. E.; MacMullen, L.; Jeter, E.; Guha, U.; Muzithras, V. P.; Zikaras, K.; Johnson, M. L.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogene-driven resectable non-small cell lung cancer (NSCLC)

Meeting Abstract

Rosner, S.; Sivapalan, L.; Zahurak, M.; Thummalapalli, R.; Rayes, R.; Connor, S.; Sanber, K.; Reuss, J. E.; Pereira, G.; Smith, K. N.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with BRAF V600E-mutant (BRAF (V600E)) metastatic non-small cell lung cancer (NSCLC) from the phase 2 PHAROS study

Meeting Abstract

Riely, G. J.; Smit, E. F.; Ahn, M. J.; Felip, E.; Ramalingam, S. S.; Tsao, A. S.; Johnson, M. L.; Gelsomino, F.; Esper, R. M.; Nadal, E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers

Meeting Abstract

Tendler, S.; Hoang, T. T.; Bauer, D.; Korsen, J.; Michel, A.; Degregorio, R.; Carter, L.; Pillarsetty, N.; Poirier, J. T.; Lewis, J. S.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save